Content provided in partnership with

New Research Institute Dedicated

BT Catalyst, Oct, 1999

The new Biomedical/Biotechnology Research Institute at North Carolina Central University in Durham was formally dedicated in September and named after Chancellor Julius L. Chambers.

Chambers is credited for leading the effort to give NCCU a competitive scientific edge. He sought collaborations with industry and other educators and finally secured approval and financial support for the construction of the $12.2 million facility in 1996.

The new 40,000-square-foot facility was designed to support research in the areas of cardiovascular diseases, environmental toxicology and carcinogenesis, neurosciences and infectious diseases. Efforts are also being made to establish a drug abuse research program.

Most Popular Articles in Technology: An overview of continuous data protection; Why all those current ratings?; Many countries now have a mobile penetration rate above 100%, report says; The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...; MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...; More »

The dedication ceremony attracted a number of public figures, including Molly Corbett Broad, president of the University of North Carolina; and Robert A. Ingram, president and CEO of Glaxo Wellcome Inc., which contributed $1 million and staff volunteers to help build the new facility.

NCCU receives funding for its biotechnology-related education programs through the Historically Minority Universities Program at the North Carolina Biotechnology Center.

Technology Industry

New Research Institute Dedicated

BT Catalyst, Oct, 1999

Find Research Guides for:

Find Featured Titles for: News

Most Popular Articles in Technology

Most Popular Publications in Technology